Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial

A. De Franco, E.; O’Brien, John; D. Adair, C.; Lewis, Daniel; Hall, David; Fusey, Shalini; Soma‐Pillay, Priya; B. Porter, Kathy; How, H.; Schakis, R.; P. Eller, Daniel; Trivedi, Yamini; VanBuren, George; Khandelwal, Meena; F. Trofatter, Kenneth; Vidyadhari, D.; Vijayaraghavan, Jaya; W. Weeks, J.; J. Dattel, Bonnie; R. Newton, Edward; Chazotte, Cynthia; J. Valenzuela, Guillermo; Calda, Pavel; Bsharat, M.; W. Creasy, George

doi:10.1002/uog.5159

Public

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial

Published in Ultrasound in Obstetrics and Gynecology • Sep 26, 2007

Authors:

E. A. De Franco

John O’Brien

C. D. Adair

Abstract

OBJECTIVE: To investigate the efficacy of vaginal progesterone to prevent early preterm birth in women with sonographic evidence of a short cervical length in the midtrimester. METHODS: This was a planned, but modified, secondary analysis of our multinational, multicenter, randomized, placebo-contro...

Subject

Medicine

Gestation

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!